- Home
- MRK
as 11-12-2025 3:39pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | RAHWAY |
| Market Cap: | 218.8B | IPO Year: | N/A |
| Target Price: | $105.29 | AVG Volume (30 days): | 10.7M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.56 | EPS Growth: | 58.08 |
| 52 Week Low/High: | $73.31 - $105.07 | Next Earning Date: | 10-30-2025 |
| Revenue: | $64,235,000,000 | Revenue Growth: | 1.68% |
| Revenue Growth (this year): | 1.82% | Revenue Growth (next year): | 5.10% |
Stock Insider Trading Activity of Merck & Company Inc. (new) (MRK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Downing Cristal N | MRK | Chief Comm. & Public Afrs Ofcr | Nov 10 '25 | Sell | $87.00 | 7,085 | $616,395.00 | 0 | |
| Williams David Michael | MRK | EVP,Chief Info&Digital Officer | Nov 3 '25 | Sell | $83.59 | 8,614 | $720,039.95 | 24,578.031 |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
Motley Fool
13 hours ago
2 Stocks Down 13% and 34% to Buy Right Now
MT Newswires
14 hours ago
Stocks Gain Pre-Bell Ahead of Looming House Vote to End Government Shutdown
StockStory
a day ago
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
StockStory
a day ago
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
StockStory
a day ago
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
StockStory
a day ago
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
StockStory
a day ago
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
StockStory
a day ago
Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.